Cabot (NYSE:CBT – Get Free Report) will be announcing its earnings results after the market closes on Monday, November 6th. Analysts expect the company to announce earnings of $1.47 per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.
Cabot (NYSE:CBT – Get Free Report) last issued its quarterly earnings results on Monday, August 7th. The specialty chemicals company reported $1.42 earnings per share for the quarter, missing analysts’ consensus estimates of $1.56 by ($0.14). The company had revenue of $968.00 million during the quarter, compared to analyst estimates of $1.09 billion. Cabot had a net margin of 7.48% and a return on equity of 25.98%. The business’s revenue for the quarter was down 15.8% on a year-over-year basis. During the same period in the prior year, the business earned $1.73 EPS. On average, analysts expect Cabot to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.
Cabot Stock Performance
Shares of Cabot stock opened at $65.66 on Monday. The company has a debt-to-equity ratio of 0.86, a current ratio of 2.17 and a quick ratio of 1.37. The firm has a market cap of $3.67 billion, a P/E ratio of 12.41, a P/E/G ratio of 2.12 and a beta of 1.29. The firm has a 50 day simple moving average of $69.25 and a 200 day simple moving average of $69.84. Cabot has a fifty-two week low of $63.73 and a fifty-two week high of $83.74.
Analyst Ratings Changes
Hedge Funds Weigh In On Cabot
Hedge funds and other institutional investors have recently made changes to their positions in the company. Virtu Financial LLC bought a new position in shares of Cabot during the fourth quarter worth $258,000. Engineers Gate Manager LP bought a new stake in Cabot in the 1st quarter valued at $255,000. Snowden Capital Advisors LLC lifted its position in Cabot by 5.6% in the 1st quarter. Snowden Capital Advisors LLC now owns 3,323 shares of the specialty chemicals company’s stock valued at $255,000 after acquiring an additional 176 shares in the last quarter. Cullen Capital Management LLC bought a new stake in Cabot in the 1st quarter valued at $239,000. Finally, Creative Planning bought a new stake in Cabot in the 2nd quarter valued at $236,000. 91.05% of the stock is owned by institutional investors.
Cabot Company Profile
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
- Five stocks we like better than Cabot
- How to Invest in Semiconductors
- Is domestic travel back on track? Check out these companies
- 3 Grocery Stocks That Are Proving They Are Still Essential
- MarketBeat Week in Review – 10/23 – 10/27
- How to Invest in the Best Canadian Stocks
- Can casino stocks win big if economy slows?
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.